nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—ADRA2A—type 2 diabetes mellitus	0.39	1	CbGaD
Molindone—HTR7—Bromocriptine—type 2 diabetes mellitus	0.139	0.354	CbGbCtD
Molindone—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0668	0.17	CbGbCtD
Molindone—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0639	0.163	CbGbCtD
Molindone—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0639	0.163	CbGbCtD
Molindone—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0589	0.15	CbGbCtD
Molindone—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00566	0.113	CbGeAlD
Molindone—HTR2A—arteriole—type 2 diabetes mellitus	0.00554	0.111	CbGeAlD
Molindone—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00381	0.076	CbGeAlD
Molindone—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00353	0.0705	CbGeAlD
Molindone—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00275	0.0548	CbGeAlD
Molindone—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00237	0.0474	CbGeAlD
Molindone—HTR2A—hindlimb—type 2 diabetes mellitus	0.0022	0.0438	CbGeAlD
Molindone—HTR7—artery—type 2 diabetes mellitus	0.00216	0.0431	CbGeAlD
Molindone—HTR7—nerve—type 2 diabetes mellitus	0.00214	0.0428	CbGeAlD
Molindone—DRD2—nerve—type 2 diabetes mellitus	0.00203	0.0404	CbGeAlD
Molindone—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.00202	0.0402	CbGeAlD
Molindone—Libido increased—Bromocriptine—type 2 diabetes mellitus	0.00199	0.0237	CcSEcCtD
Molindone—HTR7—endothelium—type 2 diabetes mellitus	0.00182	0.0364	CbGeAlD
Molindone—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00171	0.0342	CbGeAlD
Molindone—HTR2A—artery—type 2 diabetes mellitus	0.00135	0.0269	CbGeAlD
Molindone—HTR2A—nerve—type 2 diabetes mellitus	0.00134	0.0267	CbGeAlD
Molindone—Dyskinesia—Bromocriptine—type 2 diabetes mellitus	0.00129	0.0153	CcSEcCtD
Molindone—Weight increased—Linagliptin—type 2 diabetes mellitus	0.00123	0.0146	CcSEcCtD
Molindone—HTR2A—endothelium—type 2 diabetes mellitus	0.00114	0.0227	CbGeAlD
Molindone—Disturbance in sexual arousal—Glipizide—type 2 diabetes mellitus	0.00104	0.0123	CcSEcCtD
Molindone—Amenorrhoea—Orlistat—type 2 diabetes mellitus	0.00103	0.0122	CcSEcCtD
Molindone—Salivary hypersecretion—Gliclazide—type 2 diabetes mellitus	0.000965	0.0115	CcSEcCtD
Molindone—Weight increased—Rosiglitazone—type 2 diabetes mellitus	0.000938	0.0112	CcSEcCtD
Molindone—Leukopenia—Tolbutamide—type 2 diabetes mellitus	0.000932	0.0111	CcSEcCtD
Molindone—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000881	0.0176	CbGeAlD
Molindone—Disturbance in sexual arousal—Bromocriptine—type 2 diabetes mellitus	0.000872	0.0104	CcSEcCtD
Molindone—Leukopenia—Tolazamide—type 2 diabetes mellitus	0.000848	0.0101	CcSEcCtD
Molindone—Leukopenia—Chlorpropamide—type 2 diabetes mellitus	0.000848	0.0101	CcSEcCtD
Molindone—DRD2—retina—type 2 diabetes mellitus	0.000839	0.0167	CbGeAlD
Molindone—Urinary retention—Bromocriptine—type 2 diabetes mellitus	0.000836	0.00995	CcSEcCtD
Molindone—Tremor—Nateglinide—type 2 diabetes mellitus	0.000823	0.0098	CcSEcCtD
Molindone—Constipation—Miglitol—type 2 diabetes mellitus	0.000809	0.00963	CcSEcCtD
Molindone—Drowsiness—Glipizide—type 2 diabetes mellitus	0.000805	0.00958	CcSEcCtD
Molindone—Weight increased—Pioglitazone—type 2 diabetes mellitus	0.000787	0.00937	CcSEcCtD
Molindone—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000785	0.0157	CbGeAlD
Molindone—Weight decreased—Pioglitazone—type 2 diabetes mellitus	0.000782	0.00932	CcSEcCtD
Molindone—Weight increased—Glimepiride—type 2 diabetes mellitus	0.000766	0.00913	CcSEcCtD
Molindone—Weight increased—Sitagliptin—type 2 diabetes mellitus	0.000764	0.0091	CcSEcCtD
Molindone—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000761	0.0152	CbGeAlD
Molindone—Dysphagia—Bromocriptine—type 2 diabetes mellitus	0.00076	0.00905	CcSEcCtD
Molindone—Drowsiness—Glimepiride—type 2 diabetes mellitus	0.000751	0.00894	CcSEcCtD
Molindone—HTR7—cardiovascular system—type 2 diabetes mellitus	0.00075	0.015	CbGeAlD
Molindone—HTR7—kidney—type 2 diabetes mellitus	0.000734	0.0147	CbGeAlD
Molindone—Leukopenia—Repaglinide—type 2 diabetes mellitus	0.00068	0.0081	CcSEcCtD
Molindone—Drowsiness—Bromocriptine—type 2 diabetes mellitus	0.000677	0.00807	CcSEcCtD
Molindone—Leukocytosis—Ramipril—type 2 diabetes mellitus	0.000674	0.00803	CcSEcCtD
Molindone—Constipation—Linagliptin—type 2 diabetes mellitus	0.000655	0.0078	CcSEcCtD
Molindone—Leukopenia—Rosiglitazone—type 2 diabetes mellitus	0.000643	0.00766	CcSEcCtD
Molindone—Constipation—Acarbose—type 2 diabetes mellitus	0.000635	0.00757	CcSEcCtD
Molindone—Salivary hypersecretion—Ramipril—type 2 diabetes mellitus	0.000615	0.00733	CcSEcCtD
Molindone—Muscle spasms—Glipizide—type 2 diabetes mellitus	0.000604	0.0072	CcSEcCtD
Molindone—Rash—Miglitol—type 2 diabetes mellitus	0.000596	0.0071	CcSEcCtD
Molindone—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000596	0.00709	CcSEcCtD
Molindone—Vision blurred—Glipizide—type 2 diabetes mellitus	0.000593	0.00706	CcSEcCtD
Molindone—Tremor—Glipizide—type 2 diabetes mellitus	0.000589	0.00702	CcSEcCtD
Molindone—Muscle spasms—Pioglitazone—type 2 diabetes mellitus	0.000579	0.0069	CcSEcCtD
Molindone—Weight increased—Gliclazide—type 2 diabetes mellitus	0.000567	0.00676	CcSEcCtD
Molindone—Gynaecomastia—Ramipril—type 2 diabetes mellitus	0.000567	0.00675	CcSEcCtD
Molindone—Leukopenia—Glipizide—type 2 diabetes mellitus	0.000563	0.0067	CcSEcCtD
Molindone—Muscle spasms—Sitagliptin—type 2 diabetes mellitus	0.000562	0.0067	CcSEcCtD
Molindone—Nausea—Miglitol—type 2 diabetes mellitus	0.000562	0.00669	CcSEcCtD
Molindone—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.000556	0.00662	CcSEcCtD
Molindone—HTR2A—retina—type 2 diabetes mellitus	0.000553	0.011	CbGeAlD
Molindone—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.000553	0.00659	CcSEcCtD
Molindone—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.000551	0.00657	CcSEcCtD
Molindone—Tremor—Glimepiride—type 2 diabetes mellitus	0.00055	0.00655	CcSEcCtD
Molindone—Agitation—Glimepiride—type 2 diabetes mellitus	0.000539	0.00642	CcSEcCtD
Molindone—Rash—Tolbutamide—type 2 diabetes mellitus	0.000536	0.00638	CcSEcCtD
Molindone—ADRA2A—pancreas—type 2 diabetes mellitus	0.000535	0.0107	CbGeAlD
Molindone—Disturbance in sexual arousal—Losartan—type 2 diabetes mellitus	0.000532	0.00634	CcSEcCtD
Molindone—Constipation—Repaglinide—type 2 diabetes mellitus	0.00053	0.00632	CcSEcCtD
Molindone—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.000525	0.00626	CcSEcCtD
Molindone—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000524	0.0105	CbGeAlD
Molindone—Muscle spasms—Bromocriptine—type 2 diabetes mellitus	0.000509	0.00606	CcSEcCtD
Molindone—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000505	0.00602	CcSEcCtD
Molindone—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.000501	0.00597	CcSEcCtD
Molindone—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.000499	0.00594	CcSEcCtD
Molindone—Dysphagia—Irbesartan—type 2 diabetes mellitus	0.000492	0.00586	CcSEcCtD
Molindone—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.000489	0.00582	CcSEcCtD
Molindone—Rash—Tolazamide—type 2 diabetes mellitus	0.000488	0.00581	CcSEcCtD
Molindone—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000488	0.00581	CcSEcCtD
Molindone—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.000487	0.0058	CcSEcCtD
Molindone—Agitation—Bromocriptine—type 2 diabetes mellitus	0.000486	0.00579	CcSEcCtD
Molindone—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000485	0.00969	CbGeAlD
Molindone—Rash—Linagliptin—type 2 diabetes mellitus	0.000483	0.00575	CcSEcCtD
Molindone—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000482	0.00574	CcSEcCtD
Molindone—Rash—Acarbose—type 2 diabetes mellitus	0.000469	0.00558	CcSEcCtD
Molindone—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000468	0.00558	CcSEcCtD
Molindone—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000468	0.00934	CbGeAlD
Molindone—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000467	0.00557	CcSEcCtD
Molindone—Drowsiness—Metformin—type 2 diabetes mellitus	0.000465	0.00554	CcSEcCtD
Molindone—HTR7—liver—type 2 diabetes mellitus	0.000464	0.00926	CbGeAlD
Molindone—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000459	0.00547	CcSEcCtD
Molindone—Nausea—Tolazamide—type 2 diabetes mellitus	0.000459	0.00547	CcSEcCtD
Molindone—HTR2A—kidney—type 2 diabetes mellitus	0.000458	0.00914	CbGeAlD
Molindone—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000457	0.00545	CcSEcCtD
Molindone—Somnolence—Glipizide—type 2 diabetes mellitus	0.000456	0.00543	CcSEcCtD
Molindone—Disturbance in sexual arousal—Ramipril—type 2 diabetes mellitus	0.000456	0.00543	CcSEcCtD
Molindone—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000456	0.00543	CcSEcCtD
Molindone—Tremor—Glyburide—type 2 diabetes mellitus	0.000453	0.0054	CcSEcCtD
Molindone—Rash—Nateglinide—type 2 diabetes mellitus	0.000452	0.00538	CcSEcCtD
Molindone—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000451	0.00538	CcSEcCtD
Molindone—Weight increased—Irbesartan—type 2 diabetes mellitus	0.000448	0.00534	CcSEcCtD
Molindone—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000447	0.00533	CcSEcCtD
Molindone—Nausea—Acarbose—type 2 diabetes mellitus	0.000441	0.00526	CcSEcCtD
Molindone—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000441	0.00525	CcSEcCtD
Molindone—Constipation—Glipizide—type 2 diabetes mellitus	0.000439	0.00523	CcSEcCtD
Molindone—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000438	0.00522	CcSEcCtD
Molindone—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000433	0.00516	CcSEcCtD
Molindone—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000427	0.00509	CcSEcCtD
Molindone—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000426	0.00507	CcSEcCtD
Molindone—Nausea—Nateglinide—type 2 diabetes mellitus	0.000426	0.00507	CcSEcCtD
Molindone—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000424	0.00505	CcSEcCtD
Molindone—Weight increased—Losartan—type 2 diabetes mellitus	0.000422	0.00502	CcSEcCtD
Molindone—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000422	0.00502	CcSEcCtD
Molindone—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000408	0.00486	CcSEcCtD
Molindone—Tremor—Gliclazide—type 2 diabetes mellitus	0.000407	0.00485	CcSEcCtD
Molindone—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000404	0.00481	CcSEcCtD
Molindone—Agitation—Gliclazide—type 2 diabetes mellitus	0.000399	0.00476	CcSEcCtD
Molindone—Dysphagia—Ramipril—type 2 diabetes mellitus	0.000397	0.00473	CcSEcCtD
Molindone—Rash—Repaglinide—type 2 diabetes mellitus	0.000391	0.00466	CcSEcCtD
Molindone—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000391	0.00465	CcSEcCtD
Molindone—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000389	0.00463	CcSEcCtD
Molindone—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000385	0.00459	CcSEcCtD
Molindone—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000384	0.00457	CcSEcCtD
Molindone—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000384	0.00457	CcSEcCtD
Molindone—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000379	0.00452	CcSEcCtD
Molindone—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000376	0.00448	CcSEcCtD
Molindone—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000372	0.00443	CcSEcCtD
Molindone—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00037	0.0044	CcSEcCtD
Molindone—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000369	0.0044	CcSEcCtD
Molindone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000369	0.0044	CcSEcCtD
Molindone—Hypotension—Glyburide—type 2 diabetes mellitus	0.000369	0.0044	CcSEcCtD
Molindone—Nausea—Repaglinide—type 2 diabetes mellitus	0.000368	0.00439	CcSEcCtD
Molindone—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000362	0.00431	CcSEcCtD
Molindone—Weight increased—Ramipril—type 2 diabetes mellitus	0.000362	0.00431	CcSEcCtD
Molindone—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000352	0.00419	CcSEcCtD
Molindone—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000349	0.00416	CcSEcCtD
Molindone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000348	0.00415	CcSEcCtD
Molindone—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000346	0.00412	CcSEcCtD
Molindone—Vision blurred—Metformin—type 2 diabetes mellitus	0.000343	0.00408	CcSEcCtD
Molindone—Tremor—Metformin—type 2 diabetes mellitus	0.000341	0.00406	CcSEcCtD
Molindone—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000332	0.00396	CcSEcCtD
Molindone—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000331	0.00395	CcSEcCtD
Molindone—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.00033	0.00393	CcSEcCtD
Molindone—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000328	0.00391	CcSEcCtD
Molindone—Rash—Glipizide—type 2 diabetes mellitus	0.000324	0.00385	CcSEcCtD
Molindone—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000323	0.00385	CcSEcCtD
Molindone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000323	0.00385	CcSEcCtD
Molindone—Tremor—Irbesartan—type 2 diabetes mellitus	0.000321	0.00383	CcSEcCtD
Molindone—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000316	0.00377	CcSEcCtD
Molindone—Agitation—Irbesartan—type 2 diabetes mellitus	0.000315	0.00376	CcSEcCtD
Molindone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000315	0.00375	CcSEcCtD
Molindone—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00031	0.0037	CcSEcCtD
Molindone—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000307	0.00366	CcSEcCtD
Molindone—Nausea—Glipizide—type 2 diabetes mellitus	0.000305	0.00363	CcSEcCtD
Molindone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000304	0.00363	CcSEcCtD
Molindone—Vision blurred—Losartan—type 2 diabetes mellitus	0.000304	0.00362	CcSEcCtD
Molindone—Constipation—Gliclazide—type 2 diabetes mellitus	0.000303	0.00361	CcSEcCtD
Molindone—Tremor—Losartan—type 2 diabetes mellitus	0.000302	0.0036	CcSEcCtD
Molindone—Rash—Glimepiride—type 2 diabetes mellitus	0.000302	0.0036	CcSEcCtD
Molindone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000302	0.00359	CcSEcCtD
Molindone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000301	0.00358	CcSEcCtD
Molindone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000301	0.00358	CcSEcCtD
Molindone—Agitation—Losartan—type 2 diabetes mellitus	0.000297	0.00353	CcSEcCtD
Molindone—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00029	0.00346	CcSEcCtD
Molindone—Somnolence—Valsartan—type 2 diabetes mellitus	0.00029	0.00345	CcSEcCtD
Molindone—HTR2A—liver—type 2 diabetes mellitus	0.000289	0.00578	CbGeAlD
Molindone—Leukopenia—Losartan—type 2 diabetes mellitus	0.000289	0.00344	CcSEcCtD
Molindone—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000286	0.0034	CcSEcCtD
Molindone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000284	0.00339	CcSEcCtD
Molindone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000284	0.00338	CcSEcCtD
Molindone—Constipation—Valsartan—type 2 diabetes mellitus	0.000279	0.00332	CcSEcCtD
Molindone—Hypotension—Metformin—type 2 diabetes mellitus	0.000277	0.0033	CcSEcCtD
Molindone—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000273	0.00325	CcSEcCtD
Molindone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000272	0.00324	CcSEcCtD
Molindone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000272	0.00324	CcSEcCtD
Molindone—Dry mouth—Losartan—type 2 diabetes mellitus	0.000269	0.0032	CcSEcCtD
Molindone—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000266	0.00317	CcSEcCtD
Molindone—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000265	0.00315	CcSEcCtD
Molindone—Somnolence—Metformin—type 2 diabetes mellitus	0.000264	0.00314	CcSEcCtD
Molindone—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000262	0.00312	CcSEcCtD
Molindone—Tremor—Ramipril—type 2 diabetes mellitus	0.000259	0.00309	CcSEcCtD
Molindone—Tachycardia—Losartan—type 2 diabetes mellitus	0.000257	0.00306	CcSEcCtD
Molindone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000257	0.00306	CcSEcCtD
Molindone—Agitation—Ramipril—type 2 diabetes mellitus	0.000254	0.00303	CcSEcCtD
Molindone—Constipation—Metformin—type 2 diabetes mellitus	0.000254	0.00302	CcSEcCtD
Molindone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00025	0.00297	CcSEcCtD
Molindone—Rash—Glyburide—type 2 diabetes mellitus	0.000249	0.00297	CcSEcCtD
Molindone—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000249	0.00296	CcSEcCtD
Molindone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000249	0.00296	CcSEcCtD
Molindone—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000248	0.00295	CcSEcCtD
Molindone—Hypotension—Losartan—type 2 diabetes mellitus	0.000246	0.00293	CcSEcCtD
Molindone—Constipation—Irbesartan—type 2 diabetes mellitus	0.000239	0.00285	CcSEcCtD
Molindone—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000235	0.0028	CcSEcCtD
Molindone—Nausea—Glyburide—type 2 diabetes mellitus	0.000235	0.00279	CcSEcCtD
Molindone—Somnolence—Losartan—type 2 diabetes mellitus	0.000234	0.00279	CcSEcCtD
Molindone—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00023	0.00275	CcSEcCtD
Molindone—Constipation—Losartan—type 2 diabetes mellitus	0.000225	0.00268	CcSEcCtD
Molindone—Rash—Gliclazide—type 2 diabetes mellitus	0.000224	0.00266	CcSEcCtD
Molindone—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000223	0.00266	CcSEcCtD
Molindone—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000221	0.00263	CcSEcCtD
Molindone—Hypotension—Ramipril—type 2 diabetes mellitus	0.000211	0.00251	CcSEcCtD
Molindone—Nausea—Gliclazide—type 2 diabetes mellitus	0.000211	0.00251	CcSEcCtD
Molindone—Rash—Valsartan—type 2 diabetes mellitus	0.000205	0.00245	CcSEcCtD
Molindone—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000205	0.00244	CcSEcCtD
Molindone—Rash—Orlistat—type 2 diabetes mellitus	0.000203	0.00242	CcSEcCtD
Molindone—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000203	0.00242	CcSEcCtD
Molindone—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000201	0.0024	CcSEcCtD
Molindone—Somnolence—Ramipril—type 2 diabetes mellitus	0.000201	0.00239	CcSEcCtD
Molindone—Nausea—Valsartan—type 2 diabetes mellitus	0.000194	0.00231	CcSEcCtD
Molindone—Constipation—Ramipril—type 2 diabetes mellitus	0.000193	0.0023	CcSEcCtD
Molindone—Nausea—Orlistat—type 2 diabetes mellitus	0.000191	0.00228	CcSEcCtD
Molindone—Rash—Metformin—type 2 diabetes mellitus	0.000187	0.00223	CcSEcCtD
Molindone—Dermatitis—Metformin—type 2 diabetes mellitus	0.000187	0.00223	CcSEcCtD
Molindone—Rash—Irbesartan—type 2 diabetes mellitus	0.000177	0.0021	CcSEcCtD
Molindone—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000176	0.0021	CcSEcCtD
Molindone—Nausea—Metformin—type 2 diabetes mellitus	0.000176	0.0021	CcSEcCtD
Molindone—Nausea—Irbesartan—type 2 diabetes mellitus	0.000166	0.00198	CcSEcCtD
Molindone—Rash—Losartan—type 2 diabetes mellitus	0.000166	0.00198	CcSEcCtD
Molindone—Dermatitis—Losartan—type 2 diabetes mellitus	0.000166	0.00198	CcSEcCtD
Molindone—Nausea—Losartan—type 2 diabetes mellitus	0.000157	0.00186	CcSEcCtD
Molindone—Rash—Ramipril—type 2 diabetes mellitus	0.000142	0.0017	CcSEcCtD
Molindone—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000142	0.0017	CcSEcCtD
Molindone—Nausea—Ramipril—type 2 diabetes mellitus	0.000134	0.0016	CcSEcCtD
Molindone—DRD2—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.57e-06	0.000103	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.57e-06	0.000103	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.55e-06	0.000103	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.54e-06	0.000103	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.51e-06	0.000103	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.5e-06	0.000102	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—LPL—type 2 diabetes mellitus	8.47e-06	0.000102	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.46e-06	0.000102	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.45e-06	0.000102	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AVP—type 2 diabetes mellitus	8.44e-06	0.000102	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.44e-06	0.000102	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.42e-06	0.000102	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.42e-06	0.000101	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.41e-06	0.000101	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.4e-06	0.000101	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.39e-06	0.000101	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	8.39e-06	0.000101	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.38e-06	0.000101	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.36e-06	0.000101	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.35e-06	0.000101	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.32e-06	0.0001	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.3e-06	0.0001	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.3e-06	0.0001	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ADCY5—type 2 diabetes mellitus	8.29e-06	9.99e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.29e-06	9.99e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	8.29e-06	9.99e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.28e-06	9.97e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—GPX1—type 2 diabetes mellitus	8.27e-06	9.96e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.25e-06	9.95e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.23e-06	9.92e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.16e-06	9.83e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—APOB—type 2 diabetes mellitus	8.15e-06	9.83e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.12e-06	9.79e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	8.11e-06	9.78e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	8.11e-06	9.77e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.08e-06	9.73e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—CD36—type 2 diabetes mellitus	8.05e-06	9.7e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.02e-06	9.67e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8e-06	9.64e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.98e-06	9.62e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PPP2CA—type 2 diabetes mellitus	7.95e-06	9.58e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	7.91e-06	9.54e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.85e-06	9.46e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—LPL—type 2 diabetes mellitus	7.79e-06	9.38e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.78e-06	9.38e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.75e-06	9.33e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	7.74e-06	9.33e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.74e-06	9.33e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.72e-06	9.3e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	7.71e-06	9.29e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AVP—type 2 diabetes mellitus	7.68e-06	9.25e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.68e-06	9.25e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.64e-06	9.21e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.64e-06	9.2e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.64e-06	9.2e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—MTHFR—type 2 diabetes mellitus	7.63e-06	9.19e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.62e-06	9.19e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.61e-06	9.17e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.58e-06	9.14e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.58e-06	9.14e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	7.55e-06	9.1e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	7.55e-06	9.1e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.53e-06	9.07e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PPARA—type 2 diabetes mellitus	7.48e-06	9.02e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.47e-06	9e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.42e-06	8.95e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APOB—type 2 diabetes mellitus	7.42e-06	8.94e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.39e-06	8.9e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.31e-06	8.8e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.3e-06	8.8e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.29e-06	8.79e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.27e-06	8.76e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AGT—type 2 diabetes mellitus	7.25e-06	8.73e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—RELA—type 2 diabetes mellitus	7.19e-06	8.66e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.17e-06	8.64e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.14e-06	8.6e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—CALM1—type 2 diabetes mellitus	7.13e-06	8.59e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	7.12e-06	8.59e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.12e-06	8.58e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—APOE—type 2 diabetes mellitus	7.1e-06	8.56e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	7.08e-06	8.54e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—APOA1—type 2 diabetes mellitus	7.02e-06	8.46e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—C3—type 2 diabetes mellitus	7.01e-06	8.45e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	6.97e-06	8.4e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.93e-06	8.36e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.79e-06	8.19e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.78e-06	8.17e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	6.77e-06	8.16e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.74e-06	8.12e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.69e-06	8.06e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.67e-06	8.04e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	6.66e-06	8.03e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.66e-06	8.02e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.65e-06	8.01e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.65e-06	8.01e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.63e-06	7.99e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	6.63e-06	7.99e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	6.63e-06	7.99e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.63e-06	7.98e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.56e-06	7.9e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.55e-06	7.89e-05	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.54e-06	7.89e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.53e-06	7.86e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	6.53e-06	7.86e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	6.53e-06	7.86e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.51e-06	7.85e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.49e-06	7.82e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.49e-06	7.82e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.48e-06	7.81e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	6.45e-06	7.78e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.45e-06	7.77e-05	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.44e-06	7.76e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.42e-06	7.73e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	6.38e-06	7.69e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.35e-06	7.65e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.26e-06	7.54e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.24e-06	7.52e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.24e-06	7.52e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.21e-06	7.49e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	6.19e-06	7.45e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.15e-06	7.42e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.13e-06	7.38e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.12e-06	7.38e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.08e-06	7.33e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.07e-06	7.31e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	6.07e-06	7.31e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.06e-06	7.31e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	6.06e-06	7.3e-05	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	6.03e-06	7.27e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.96e-06	7.18e-05	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.94e-06	7.16e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	5.94e-06	7.15e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	5.94e-06	7.15e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.93e-06	7.14e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.92e-06	7.13e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.87e-06	7.07e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.82e-06	7.02e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.79e-06	6.98e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	5.67e-06	6.83e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.66e-06	6.82e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.66e-06	6.82e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—SRC—type 2 diabetes mellitus	5.65e-06	6.81e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.6e-06	6.75e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	5.58e-06	6.72e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.58e-06	6.72e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	5.56e-06	6.7e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	5.55e-06	6.68e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.5e-06	6.63e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.49e-06	6.61e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.48e-06	6.6e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.48e-06	6.6e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.46e-06	6.57e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.45e-06	6.57e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.39e-06	6.5e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.39e-06	6.49e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.37e-06	6.47e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.36e-06	6.46e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.36e-06	6.46e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.34e-06	6.43e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.33e-06	6.42e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	5.32e-06	6.41e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	5.32e-06	6.41e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.3e-06	6.38e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.2e-06	6.27e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.12e-06	6.17e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.09e-06	6.14e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	5.07e-06	6.11e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.05e-06	6.09e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.99e-06	6.01e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.97e-06	5.99e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.97e-06	5.99e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.95e-06	5.97e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.91e-06	5.91e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.9e-06	5.91e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.89e-06	5.89e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.89e-06	5.89e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.88e-06	5.88e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	4.87e-06	5.86e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.86e-06	5.86e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.86e-06	5.86e-05	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.85e-06	5.84e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.81e-06	5.79e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.77e-06	5.75e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	4.68e-06	5.64e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.66e-06	5.61e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	4.6e-06	5.55e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.58e-06	5.52e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.54e-06	5.47e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.49e-06	5.41e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.45e-06	5.36e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.45e-06	5.36e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.4e-06	5.31e-05	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.26e-06	5.13e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.22e-06	5.08e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.19e-06	5.05e-05	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.19e-06	5.05e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	4.19e-06	5.05e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.19e-06	5.04e-05	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.17e-06	5.02e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.15e-06	5e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.13e-06	4.98e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.12e-06	4.97e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.1e-06	4.94e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.08e-06	4.91e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.99e-06	4.8e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.94e-06	4.75e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.92e-06	4.73e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.9e-06	4.7e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.88e-06	4.68e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.87e-06	4.66e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.86e-06	4.65e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.81e-06	4.59e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	3.81e-06	4.59e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.8e-06	4.58e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.78e-06	4.56e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.78e-06	4.55e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.75e-06	4.52e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.74e-06	4.51e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.68e-06	4.43e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.67e-06	4.42e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.62e-06	4.36e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.6e-06	4.33e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.58e-06	4.31e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.57e-06	4.3e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.53e-06	4.25e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.52e-06	4.24e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.51e-06	4.23e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.5e-06	4.22e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.46e-06	4.17e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.29e-06	3.96e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.29e-06	3.96e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.23e-06	3.9e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.22e-06	3.88e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.22e-06	3.88e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.2e-06	3.86e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.17e-06	3.82e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.15e-06	3.8e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.94e-06	3.54e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.88e-06	3.48e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.82e-06	3.4e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.6e-06	3.14e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.48e-06	2.98e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	2.45e-06	2.95e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.44e-06	2.94e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.42e-06	2.92e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.28e-06	2.75e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.25e-06	2.71e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.24e-06	2.69e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.22e-06	2.67e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.04e-06	2.46e-05	CbGpPWpGaD
